Skip to main content
Log in

Aetiopathology of the streptomycin ototoxicity

  • Published:
Indian Journal of Otolaryngology Aims and scope Submit manuscript

An Erratum to this article was published on 01 June 1987

Abstract

Streptomycin causes toxicity due to direct action on the organs in labyrinth. The bioavailability of drug is dependent on its dosage, absorption, metabolism and excretion. Individual variables like age, sex, nutrition, haemoglobin levels. renal functions do not appear to lead to predispose the ototoxicity. The drug dosage and combinations of other drugs were considered in studying the ototoxicity. It is observed that serum levels of more than 2.5 microgram per milliliters predispose dispose to ototoxicity. So also the subjects having higher than 2.5 mgms/ml in serum at the 24th hour following single injection of drug are more vulnerable, (P<0.05) on the otherhand initial higher level at the end of 1st hour (mean 54.75 ugm/ml) do not have positive relationship with toxicity (P<0.05). Furthermore streptomycin appears to be more damaging to static than dynamic part of labyrinth and the later is more vulnerable than cochlear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Berg (1951) : Toxic effect of streptomycin on vestibular and cochlear afferents, an experimental study in casts,Acta Suppl. 97.

  2. Bignell, J. R., and Thomas, J. A. B. (1951): Effect of streptomycin on vestibular function,British Medical Journal,1 : 554.

    Google Scholar 

  3. Bosher (1976) : S. K. Scientific Foundation of Otolaryngology Ed. Hinchliffe, R. and HarrisonD.F. M. London, Heinemann Page 292.

  4. Cruickshank, R. (1975) in Medical Microbiology London, Edinburgh,Churchill Livingston 12th Ed. Vol. II.

  5. Farrington, R. F., Hull Smith, H., Bunn, P. A. and Mc Dermott, W. Streptomycin toxicity,Journal American Medical Association,134 : 679.

  6. Leggat and Girifford (1952) Uncommon neurotoxic Symptom associated with Dihydrostreptomycin therapy,British Medical Journal 1: 1008.

    Article  PubMed  CAS  Google Scholar 

  7. Mishra, S. C. & Bera, S. P. (1981) Neurootological profile of streptomycin ototoxicity, Indian Journal ofOtolaryngology 33:1.

    Google Scholar 

  8. Tumarkin (1951) in Scientific Foundation in Otolaryngology, Ed. Hinchcliffe R. and Harrison,London, Hencmann, 1976.

    Google Scholar 

  9. Yassin, A and Taha, M, (1965) Hearing disorders in Secondary Anaemia,Journal of Larynglogy and Otology,79: 917.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/BF02995370.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhateja, D.K., Mishra, S.C., Nath, J. et al. Aetiopathology of the streptomycin ototoxicity. Indian J Otolaryngol 38, 69–71 (1986). https://doi.org/10.1007/BF03020144

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03020144

Keywords

Navigation